Zelluna Immunotherapy
Blood & Organ Banks · Norway · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ullernchausséen 64, Oslo, Oslo, 0379, No...Phone Number
+46 859478830Website
www.zelluna.comRevenue
$6.3 MillionIndustry
ZI Rank: 2
About Zelluna Immunotherapy
Zelluna Immunotherapy Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zelluna Immunotherapy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Zelluna Immunotherapy has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Zelluna Immunotherapy recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Zelluna Immunotherapy
Funding: Get notified immidiatlly once Zelluna Immunotherapy has new funding data
Product Launch: Get notified when Zelluna Immunotherapy launches new products
Check out if Zelluna Immunotherapy is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Zelluna Immunotherapy, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Zelluna Immunotherapy had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Zelluna Immunotherapy as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Zelluna Immunotherapy is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Zelluna Immunotherapy is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Zelluna Immunotherapy.
Zelluna Immunotherapy financials insights
Gather financial insights about Zelluna Immunotherapy, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$8.5M
Other Financing Round
$6M
Zelluna Immunotherapy Tech Stack
A closer look at the technologies used by Zelluna Immunotherapy
Most Recent Scoops
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zelluna Immunotherapy
Zelluna is a pioneering company developing novel cell therapies specifically targeting solid cancers to improve treatment outcomes for cancer patients. The company focuses on its proprietary TCR-NK cell therapy platform, which aims to overcome existing challenges in solid cancer treatment. Zelluna's experienced team and strong intellectual property... Read More
